文献速递睡眠呼吸障碍

睡眠呼吸暂停特异性健康状态效用算法的开发

Development of a Sleep Apnea-Specific Health State Utility Algorithm.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2020-01-01

在2家三级睡眠中心,利用随机临床试验和观察性队列中新诊断的阻塞性睡眠呼吸暂停患者,将SNORE-25量表通过多元线性回归映射到SF-6D效用指数,开发并验证了SNORE效用指数。开发样本r²=0.32,验证样本r²=0.33,为睡眠呼吸暂停研究提供了经验证的疾病特异性效用工具。

要点

  • SNORE效用指数经开发与验证,可用于睡眠呼吸暂停患者的效用测量。
  • 开发样本r²=0.32,验证样本r²=0.33。
  • 未治疗睡眠呼吸暂停患者平均SF-6D效用为0.61。

核心结论

  • SNORE效用指数是一种经验证的、疾病特异性、偏好加权的效用工具,可用于未来阻塞性睡眠呼吸暂停患者的研究。

研究设计与样本

  • 开发与验证在2家三级转诊睡眠中心及相关睡眠门诊进行,纳入随机临床试验和观察性队列中新诊断的阻塞性睡眠呼吸暂停患者。
  • 基线参与者随机分为模型开发组(60%)和交叉验证组(40%)。

主要发现

  • 共纳入500名参与者(开发组n=300,验证组n=200),其中男性295名(59%),平均(SD)年龄48.6(12.8)岁,范围18至90岁。
  • 未治疗睡眠呼吸暂停参与者的平均(SD)SF-6D效用为0.61(0.08;范围0.40-0.85),不同严重程度组间效用相似。
  • 最佳拟合模型(SNORE效用指数)为量表子量表的自然对数转换,开发样本r²=0.32,验证样本r²=0.33。

临床怎么用

  • SNORE效用指数可用于阻塞性睡眠呼吸暂停患者的经济学评价和效用测量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: With the increasing emphasis on economic evaluations, there is a need for additional methods of measuring patient utility in the obstructive sleep apnea population. OBJECTIVE: To develop and validate a utility scoring algorithm for a sleep apnea-specific quality-of-life instrument. DESIGN, SETTING, AND PARTICIPANTS: Development and validation were conducted at 2 tertiary referral sleep centers and associated sleep clinics and included patients with newly diagnosed obstructive sleep apnea from a randomized clinical trial and an associated observational cohort study. Baseline participants were randomly divided into a model development group (60%) and a cross-validation group (40%). MAIN OUTCOMES AND MEASURES: Utility scoring of the Symptoms of Nocturnal Obstruction and Related Events (SNORE-25) was mapped from the SF-6D utility index through multiple linear regression in the development sample using the Akaike information criterion to determine the best model. RESULTS: A total of 500 participants (development, n = 300; validation, n = 200) were enrolled; the analyzed sample of 500 participants included 295 men (59%), and the mean (SD) age was 48.6 (12.8) years, with a range of 18 to 90 years. The mean (SD) SF-6D utility among participants with untreated sleep apnea was 0.61 (0.08; range, 0.40-0.85) with similar utility across sleep apnea severity groups. The best-fit model (the SNORE Utility Index) was the natural log conversion of the instrument subscales (r2 = 0.32 in the development sample). The SNORE Utility Index retained this association within the validation sample (r2 = 0.33). CONCLUSIONS AND RELEVANCE: The SNORE Utility Index provides a validated, disease-specific, preference-weighted utility instrument that can be used in future studies of patients with obstructive sleep apnea.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Skirko JR, James KT, Garrison LP, et al. Development of a Sleep Apnea-Specific Health State Utility Algorithm. JAMA Otolaryngol Head Neck Surg. 2020. PMID: 31999308. doi:10.1001/jamaoto.2019.4469

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。